Cidara Therapeutics stock price target raised to $173 by Citizens
PositiveFinancial Markets

Cidara Therapeutics has received a significant boost as Citizens has raised its stock price target to $173. This positive adjustment reflects growing confidence in the company's potential and could attract more investors looking for promising opportunities in the biotech sector. Such developments are crucial as they can influence market trends and investor sentiment.
— Curated by the World Pulse Now AI Editorial System